Intercept Pharmaceuticals Inc


Seite 1 von 9
Neuester Beitrag: 26.09.23 16:05
Eröffnet am:09.01.14 14:25von: rokrocktAnzahl Beiträge:219
Neuester Beitrag:26.09.23 16:05von: VassagoLeser gesamt:79.157
Forum:Hot-Stocks Leser heute:25
Bewertet mit:
7


 
Seite: <
| 2 | 3 | 4 | 5 | 6 | 7 | 8 | 9 9  >  

5696 Postings, 4234 Tage rokrocktIntercept Pharmaceuticals Inc

 
  
    #1
7
09.01.14 14:25
Intercept Announces NASH Primary Endpoint Met: FLINT Trial Stopped Early for Efficacy Based on Highly Statistically Significa...

ntercept Pharmaceuticals, Inc. (Nasdaq:ICPT) (Intercept) today announced that the FLINT trial of obeticholic acid (OCA) for the treatment of nonalcoholic steatohepatitis (NASH) has been stopped early for efficacy based on a planned interim analysis showing that the primary endpoint of the trial has been met. FLINT is a multi-center, double-blind, placebo-controlled clinical trial assessing the safety and efficacy of a 25 mg oral dose of OCA administered daily to biopsy-proven adult NASH patients over a 72-week treatment period. The trial has been sponsored and conducted by the National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK), a part of the National Institutes of Health, at eight leading US academic hepatology centers comprising the NIDDK's NASH clinical research network (CRN).

The decision to stop FLINT has been based on the recommendation of the Data Safety Monitoring Board (DSMB) which reviewed liver biopsy data from before and at the end of the treatment period in approximately half of the 283 randomized patients, in accordance with a planned interim efficacy analysis. This analysis demonstrated that OCA treatment resulted in a highly statistically significant improvement (p=0.0024 on an intention-to-treat [ITT] basis) in the primary histological endpoint, defined as a decrease in the NAFLD Activity Score (NAS) of at least two points with no worsening of fibrosis, as compared to placebo. Those patients who had not yet completed the trial and therefore did not have a second biopsy were treated as non-responders in the ITT analysis. The pre-defined threshold of statistical significance for stopping FLINT was p < 0.0031.

"The unexpected early stopping of FLINT due to OCA meeting the primary endpoint with such high significance is a major milestone," said Mark Pruzanski, M.D., Chief Executive Officer of Intercept. "NASH has grown to epidemic proportions worldwide, having become a leading cause of cirrhosis and liver failure. On its current trajectory, the disease is projected to become the leading indication for liver transplant. We are deeply grateful to the NIDDK and the NASH CRN for their longstanding commitment both to improving our understanding of the disease and to sponsoring ambitious trials like FLINT in their quest to identify novel treatments for patients suffering from NASH."

Intercept will discuss NASH and the FLINT trial during the previously announced conference call and audio webcast scheduled to take place today at 4:30 p.m. ET. The live event will be available on the investor page of the Intercept website at http://ir.interceptpharma.com or by calling (855) 232-3919 (domestic) or (315) 625-6894 (international) five minutes prior to the start time. A replay of the call will be available on the Intercept website approximately two hours after the completion of the call and will be archived for two weeks

http://ih.advfn.com/p.php?pid=nmona&article=60606013  

5696 Postings, 4234 Tage rokrockt:-)

 
  
    #2
09.01.14 14:26
Kurs steht in DE bei 52,8€ und MM bedient mich nicht

ahhaha Schade

weil Premarket ist jetzt schon über 170$ ;-))))

 

5696 Postings, 4234 Tage rokrocktPre Market 250$ Wahnsiiin

 
  
    #3
1
09.01.14 14:53

5066 Postings, 4573 Tage einstegerzu 53,1€ kriegt man auch nichts-habs auch versucht

 
  
    #4
09.01.14 15:17

5696 Postings, 4234 Tage rokrocktMM

 
  
    #5
09.01.14 15:19
hat um 13:44 letztes mal BID/ASK aktualisiert

hehe das wäre ja Wahnsinn  

5066 Postings, 4573 Tage einstegerich habe in Frankfurt angerufen:

 
  
    #6
09.01.14 15:23
es ist dort zur Zeit von Handel "ausgesetzt"  

5696 Postings, 4234 Tage rokrocktvielicht auch gut so

 
  
    #7
09.01.14 15:26
ich denke die wird in weniger als 5min 100$ runter rauschen  

5696 Postings, 4234 Tage rokrocktgeht weiter 275$ +282%

 
  
    #8
09.01.14 15:36

5696 Postings, 4234 Tage rokrocktohaaaa 300$

 
  
    #9
09.01.14 15:38

1760 Postings, 5296 Tage jonzweitRe:

 
  
    #10
09.01.14 15:53
REIN!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!
YEAAAH!  

1760 Postings, 5296 Tage jonzweitRe:

 
  
    #11
09.01.14 15:56
JETZT FICKEN WIR DIE GANZE COTE D´AZUR!!! BOAH....ha ha ha...das wars Mann...das ist ES! ES hat zugeschlagen...Das ES!!!

HA ha ha!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!­!  

28336 Postings, 5316 Tage WeltenbummlerGibt es gründe für den Anstieg oder nur Zocken?

 
  
    #12
09.01.14 16:23
Wenn es Gründe gibt, dann bitte auf Deutsch.  

212 Postings, 4061 Tage mrnutzWas

 
  
    #13
09.01.14 21:18
Geht denn hier ab ?  

5696 Postings, 4234 Tage rokrocktNEWs sieh #1

 
  
    #14
1
09.01.14 21:24

591 Postings, 3998 Tage stier1981wenn die weiter so steigt

 
  
    #15
3
10.01.14 07:57
dann hollt sie noch Apple ein :-)  

1549 Postings, 5329 Tage OptimistinSieht sich sehr......

 
  
    #16
10.01.14 11:08
....gut in meinem Depot an!  

5696 Postings, 4234 Tage rokrocktIntercept Pharmaceuticals Inc

 
  
    #18
3
10.01.14 12:10
Pre Market wieder 345$

Wahnsiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiii­iiiiin  

2341 Postings, 4173 Tage Andrew6466Pre 350 $ mit 100 Stck.

 
  
    #19
2
10.01.14 12:13

17616 Postings, 5530 Tage M.MinningerDas ist Ramses IV

 
  
    #20
3
10.01.14 12:19
Der will die Bude im Alleingang hochziehen.   ;-))))))  

5696 Postings, 4234 Tage rokrockt@M.M

 
  
    #21
2
10.01.14 12:29
bist du dir da sicher???

35000$

hahahahahahahaah  

5696 Postings, 4234 Tage rokrocktdas ist doch abnormal

 
  
    #22
2
10.01.14 12:36
US3632252025 GALT  

23606 Postings, 5188 Tage Balu4uHammer!

 
  
    #23
2
10.01.14 12:39

2341 Postings, 4173 Tage Andrew6466Zur Zeit ...

 
  
    #24
10.01.14 12:47
... bei den Biopharmaceuticals völlig normal, liegen absolut im Trend!

Ein PLUS von knapp 87 US Dollar im PRE Market zum Vorabend kann sich sehen lassen, wo soll das heute eigentlich hingehen? 1000 US Dollar? Mal sehen, ob die wirklich spinnen, die Amis!  
 

2341 Postings, 4173 Tage Andrew6466Vielleicht von allgemeinem Interesse?!

 
  
    #25
1
10.01.14 13:12

Seite: <
| 2 | 3 | 4 | 5 | 6 | 7 | 8 | 9 9  >  
   Antwort einfügen - nach oben